![Enrique Poradosu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Enrique Poradosu
Fondatore presso
NUVECTIS PHARMA, INC.
Patrimonio netto: 41 M $ in data 31/08/2026
Profilo
Enrique Poradosu is the founder of Nuvectis Pharma, Inc., founded in 2020, and holds the title of Executive VP, Chief Scientific & Business Officer.
Former jobs include Vice President-Business & Scientific Strategy at Keryx Biopharmaceuticals, Inc. from 2003 to 2016, and Senior VP-Business & Scientific Strategy at Stemline Therapeutics, Inc. from 2016 to 2020.
Education includes undergraduate and doctorate degrees from The Hebrew University of Jerusalem.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 13/04/2026 | 1.806.319 ( 5,53% ) | 41 M $ | 31/08/2026 |
Posizioni attive di Enrique Poradosu
| Società | Posizione | Inizio |
|---|---|---|
| NUVECTIS PHARMA, INC. | Fondatore | 27/07/2020 |
Precedenti posizioni note di Enrique Poradosu
| Società | Posizione | Fine |
|---|---|---|
| STEMLINE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/12/2020 |
| KERYX BIOPHARMACEUTICALS | Direttore Tecnico/Scientifico/R&S | 01/01/2016 |
Formazione di Enrique Poradosu
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
51
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvectis Pharma, Inc.
 Nuvectis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer | Health Technology |
